Search Results - "Loglio, A"

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B by El Sharkawy, R., Thabet, K., Lampertico, P., Petta, S., Mangia, A., Berg, T., Metwally, M., Bayoumi, A., Boonstra, A., Brouwer, W. P., Smedile, A., Abate, M. L., Loglio, A., Douglas, M. W., Khan, A., Santoro, R., Fischer, J., Leeming, D. J., Liddle, C., George, J., Eslam, M.

“…Summary Background Host genetic modifiers of the natural history of chronic hepatitis B (CHB) remain poorly understood. Recently, a genome‐wide association…”
Get full text

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B by Loglio, A., Iavarone, M., Grossi, G., Viganò, M., Rumi, MG, Facchetti, F., Lunghi, G., Sangiovanni, A., Colombo, M., Lampertico, P.

“…Summary Background Long‐term oral nucleos(t)ide analogue (NUC) therapy in hepatitis B virus (HBV)‐related compensated cirrhotics prevents clinical…”
Get full text

High rates of renal tubular damage in HBV monoinfected patients long-term treated with Tenofovir: a cross-sectional, single center, real-life study in 414 patients by Lampertico, P, Grossi, G, Loglio, A, Facchetti, F, Galmozzi, E, Colombo, M

Get full text

Genetic variations in PD-1 and STAT4 genes do not predict off-treatment functional cure in IFN treated genotype D, HBeAg-negative patients with chronic hepatitis B by Galmozzi, E, Facchetti, F, Grossi, G, Loglio, A, Colombo, M, Lampertico, P

Get full text

Minimal increases of alpha-fetoprotein above the normal value strongly predict HCC development in compensated Caucasian HBV cirrhotics treated by entecavir or tenofovir: a 7-year longitudinal cohort study in 225 patients by Loglio, A, Grossi, G, Iavarone, M, Viganò, M, Sangiovanni, A, Colombo, M, Lampertico, P

Get full text

Genetic variations in PD-1 and STAT4 genes do not predict off-treatment functional cure in IFN treated genotype D, HBeAg-negative patients with chronic hepatitis B by Galmozzi, E, Facchetti, F, Grossi, G, Loglio, A, Lampertico, P

Get full text

High rates of renal tubular damage in HBV monoinfected patients long-term treated with tenofovir: A cross-sectional, single center, real-life study in 414 patients by Grossi, G, Loglio, A, Facchetti, F, Galmozzi, E, Colombo, M, Lampertico, P

Get full text

Minimal increases of alpha-fetoprotein strongly predict HCC development in caucasian compensated HBV cirrhotics treated by entecavir or tenofovir: A 7-year longitudinal cohort study in 225 patients by Loglio, A, Grossi, G, Iavarone, M, Viganò, M, Sangiovanni, A, Colombo, M, Lampertico, P

Get full text

Hepatocellular carcinoma developing in European patients with prolonged HBV suppression: Biological and clinical features, and outcome by Lampertico, P, Grossi, G, Loglio, A, Viganò, M, Facchetti, F, Invernizzi, F, Iavarone, M, Sangiovanni, A, Colombo, M

Get full text

Entecavir monotherapy improves renal function in patients developing renal side effects during long-term tenofovir treatment without compromising virological response: A multicenter real-life study in 103 patients by Viganò, M, Grossi, G, Loglio, A, Cappelletti, M, Zaltron, S, Castelli, F, Andreone, P, Messina, V, Ganga, R, Coppola, N, Marrone, A, Russello, M, Marzano, A, Taliani, G, Fasano, M, Fagiuoli, S, Villa, E, Bronte, F, Santantonio, T, Brancaccio, G, Facchetti, F, Lampertico, P

Get full text

F-13 Switching to tenofovir is safe in most CHB patients with a reduced glomerular filtration rate due to previous exposure to adefovir dipivoxil by Viganò, M, Lampertico, P, Soffredini, R, Invernizzi, F, Loglio, A, Facchetti, F, Colombo, M

Get full text

T-17 Add-on Peg-IFN improves HBsAg kinetics in HBeAg-negative patients long-term fully suppressed by nucleos(t)ide analogs by Invernizzi, F, Lampertico, P, Mangia, G, Soffredini, R, Facchetti, F, Loglio, A, Lunghi, G, Colombo, M

Get full text

OC.11.5: BULEVIRTIDE PROGRESSIVELY IMPROVES LIVER FUNCTION IN LIVER TRANSPLANT CANDIDATES WITH ADVANCED HDV CIRRHOSIS AND SEVERE PORTAL HYPERTENSION by Loglio, A., Viganò, M., Goisis, L., Farina, E., Arosio, M.E.G., Marra, P., Farina, C., Fagiuoli, S.

Get full text

Bulevirtide progressively improves liver function in liver transplant candidates with advanced HDV cirrhosis and severe portal hypertension by Loglio, A., Viganò, M., Goisis, L., Farina, E., Arosio, M.E.G., Marra, P., Farina, C., Fagiuoli, S.

Get full text

OC.16.9: NEW SKELETAL MUSCLE INDEXES TO ASSESS SARCOPENIA IN PATIENTS WITH ACLF ON ALCOHOLIC LIVER DISEASE: A SINGLE CENTER REAL-LIFE STUDY by Farina, E., Ideo, F., Bonaffini, P.A., Viganò, M., Arrigoni, A., Loglio, A., Iegri, C., Caroli, A., Marra, P., Pasulo, L., Sironi, S., Fagiuoli, S.

Get full text

BOC.01.3: LONG-TERM HIGH-RISK OF DE-NOVO HBV-HEPATITIS (DNHB) IN HBSAG-NEGATIVE LIVER TRANSPLANT RECIPIENTS OFANTI-HBC POSITIVE GRAFTS: A MULTICENTRE REAL-LIFE EXPERIENCE by Dondossola, D., Loglio, A., Viganò, M., Dibenedetto, C., Pitotti, L., Farina, E., Antonelli, B., Facchetti, F., Donato, F., Pasulo, L., Colledan, M., Caccamo, L., Fagiuoli, S., Lampertico, P.

Get full text

Impact of acute on chronic liver failure (aclf) superimposed to alcoholic cirrhosis: a single centre experience by Ideo, F., Iegri, C., Farina, E., Vigano’, M, Carioli, G., Luca’, M.G., Pasulo, L., Triolo, M., Leonardi, F., Loglio, A., Pinelli, D., Colledan, M., Fagiuoli, S.

Get full text

Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks by Degasperi, E., Anolli, M.P., Renteria, S.C. Uceda, Sambarino, D., Borghi, M., Perbellini, R., Facchetti, F., Loglio, A., Monico, Sara, Fraquelli, M., Costantino, A., Ceriotti, F., Lampertico, P.

“…Bulevirtide (BLV) has been conditionally approved for treatment of compensated chronic hepatitis Delta in Europe, however long-term outcomes of HDV patients…”
Get full text

OC.11.8: SHORT- AND LONG-TERM RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH ALCOHOLIC LIVER DISEASE (ALD) AND ACUTE ON CHRONIC LIVER FAILURE by Iegri, C., Ideo, F., Viganò, M., Farina, E., Carioli, G., De Giorgio, M., Pasulo, L., Leonardi, F., Loglio, A., Guizzetti, M., Zambelli, M., Pinelli, D., Colledan, M., Fagiuoli, S.

Get full text

Baseline predictors of virological and biochemical responses in HDV compensated cirrhotic patients treated with Bulevirtide monotherapy (HEP4Di study) by Degasperi, E., Anolli, M.P., D'Offizi, G., Brunetto, M.R., Verucchi, G., Ciancio, A., Mangia, A., Santantonio, T.A., Coppola, N., Pellicelli, A., Loglio, A., Viganò, M., Federico, A., Pileri, F., Maracci, M., Tonnini, M., Puoti, M., Lampertico, P.

Get full text